Premium
Genetic regulation of fetal haemoglobin in inherited bone marrow failure syndromes
Author(s) -
Alter Blanche P.,
Rosenberg Philip S.,
Day Thomas,
Menzel Stephan,
Giri Neelam,
Savage Sharon A.,
Thein Swee Lay
Publication year - 2013
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.12399
Subject(s) - macrocytosis , erythropoiesis , fanconi anemia , bone marrow failure , erythropoietin , ineffective erythropoiesis , bone marrow , dyskeratosis congenita , medicine , allele , anemia , immunology , endocrinology , biology , genetics , haematopoiesis , stem cell , gene , dna repair , telomere
Summary Patients with inherited bone marrow failure syndromes ( IBMFS ) have ‘stress erythropoiesis’, with anaemia, macrocytosis, increased fetal haemoglobin (Hb F) and high erythropoietin levels. In haemoglobinopathies, Hb F levels are regulated by 3 quantitative trait loci, HBS 1L‐ MYB , BCL 11A and Xmn1 ‐ HBG 2 . In our study of 97 patients with an IBMFS , increased Hb F was associated with young age, male gender, anaemia, high erythropoietin levels, and alternative alleles in Xmn1 ‐ HBG 2 [adjusted P = 0·04 for the total group, driven by Fanconi anaemia ( P = 0·02) and dyskeratosis congenita ( P = 0·09)]. Thus Hb F is regulated in IBMFS by Xmn1 ‐ HBG 2, as it is in the haemoglobinopathies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom